Technology
Health
Pharmaceutical

AcelRx Pharmaceuticals

$3.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (1.90%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ACRX and other stocks, options, ETFs, and crypto commission-free!

About

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. Read More The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

Employees
61
Headquarters
Redwood City, California
Founded
2005
Market Cap
248.88M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.94M
High Today
$3.30
Low Today
$3.07
Open Price
$3.21
Volume
857.65K
52 Week High
$5.05
52 Week Low
$1.99

Collections

Technology
Health
Pharmaceutical
US
North America

News

Seeking AlphaMar 21

AcelRx Pharmaceuticals (ACRX) Presents At Oppenheimer 29th Annual Healthcare Conference - Slideshow

The following slide deck was published by AcelRx Pharmaceuticals, Inc. in conjunction with this event. 1 45 Click to enlarge Notes:...

231
Yahoo FinanceMar 8

Here's Why Momentum Investors Will Love AcelRx Pharmaceuticals (ACRX)

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Wh...

2,327
The Motley FoolMar 4

3 Top Small-Cap Stocks to Buy Right Now

Small-cap stocks have gotten off to a blistering start in 2019. In fact, small-cap equities, on balance, have been outperforming their mid- and large-cap peers during the first two months of the year by a wide margin.

4,119

Earnings

-$0.29
-$0.25
-$0.22
-$0.18
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 8, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.